{"context":{"query":">>hgnc>>gwas","source_dataset":"hgnc","target_dataset":"gwas"},"stats":{"queried":1,"total":7,"mapped":1},"pagination":{"has_next":false},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"HGNC:5293","source":"HGNC:5293|5-hydroxytryptamine receptor 2A","targets":["GCST000960_6|Cardiac hypertrophy|RN7SL700P - SUCLA2|13|6.000000e-06","GCST001521_9|Subcutaneous adipose tissue|HTR2A - GNG5P5|13|6.000000e-06","GCST002778_8|Parkinson disease and lewy body pathology|HTR2A-AS1, HTR2A|13|2.000000e-06","GCST004061_7|Sjögren's syndrome|GNG5P5 - RN7SL700P|13|1.000000e-06","GCST005782_7|Serum 25-Hydroxyvitamin D levels|HTR2A - GNG5P5|13|4.000000e-09","GCST012490_199|Femur bone mineral density x serum urate levels interaction|HTR2A|13|8.000000e-09","GCST012796_8|Sjögren's syndrome|GNG5P5 - RN7SL700P|13|3.000000e-06"]}]}